Physician profile
Kyle Burton
NPI 1962934182
$4,866.04
in general payments reported to CMS, 2019-2025
7 companies · $3,458 in 2025
The $3,458 reported for 2025 was more than what 82% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $561 · 2024: $847 · 2025: $3,458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,616 · Consulting Fee: $2,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,616.04 |
| Consulting Fee | $2,250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,235.26 | 2023-2025 | Obsidio, Cryoablation Needles, Embold Fibered |
| Stryker Corporation | $687.14 | 2024-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Clottriever Bold Catheter |
| Inari Medical, INC. | $518.01 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Penumbra, INC. | $268.32 | 2023-2024 | Indigo System, Penumbra System |
| Sirtex Medical INC | $115.72 | 2024-2025 | Lava Les (Liquid Embolic System), Sir-Spheres Microspheres |
| Edwards Lifesciences Corporation | $22.24 | 2025 | Sapien 3 Ultra Resilia |
| Regeneron Healthcare Solutions, INC. | $19.35 | 2025 | Libtayo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Burton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.